- Joined
- 21 May 2006
- Posts
- 4
- Reactions
- 0
Anyone following this Company? They got some positive coverage on Wall St Reporter recently.
The chart does not look good. It has been going south for about one year. I guess it is too risky to invest in this one.
OK...so as of 28/6/07 PAA own's 39.5% of CBTE....thursdays close for CBTE was 3.043..making PAA share of just over $8mil AUS......fridays close of .044 for PAA-- market cap of 5mil....so now I have to dig a little deeper as to why the market has valued this one on a slippery slide for the past year..........because as of right now Im looking at one value added operation of PAA already exceeding market cap...epichem needs to be valued next. Anyone got any insight??
Sorry m8, its a dog..been in it for 12 years since it was echo tech. bottom draw stock if ever seen 1..down the **** shute
View attachment 55038
Volume still coming in - much larger now. Looks like today all the selling got soaked up though there were quite a few shares changing hands.
Moved well today, but a lot later than expected. Still holding and watching closely now. I guess I should declare I did not stick to my guns and exit after the week of no action from my entry date - perhaps very risky.
After last weeks move up by 10% I bought more. Now to see whether it can hold the move.
I still don't know much more about the company and what may be developing behind the scenes but it now warrants some investigation. Anyone else following ?
14th January 2019 – Perth, Australia: PharmAust Limited (ASX: PAA), a clinical stage oncology company that is engaged in collaboration with the Olivia Newton-John Cancer Research Institute (ONJCRI), is pleased to announce important findings confirming anti-cancer activity of monepantel’s major metabolite, monepantel sulfone.
The human cancer cell lines tested were representative of cancers that PharmAust is currently studying for treatment in its upcoming Phase II trial in humans. Importantly, the ONJCRI researchers also demonstrated that, like monepantel, the metabolite has relatively little toxicity upon non-cancer human cells.
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.